During the past decade, Pulmonary Associates of the Southeast/WCR conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Pulmonary Associates of the Southeast/WCR" are "Insomnia Disorder" (2 trials). Many other conditions were trialed in "Pulmonary Associates of the Southeast/WCR" in a lesser frequency.

Most popular intervention types in "Pulmonary Associates of the Southeast/WCR" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Daridorexant 25 mg" (2 trials), "Daridorexant 50 mg" (2 trials), "Placebo" (2 trials) and "Daridorexant 10 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pulmonary Associates of the Southeast/WCR" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Pulmonary Associates of the Southeast/WCR". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Pulmonary Associates of the Southeast/WCR, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pulmonary Associates of the Southeast/WCR, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".